What is the Aurobindo Pharma Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 17.41% of the total equity shares of Aurobindo Pharma Ltd.

What is the Aurobindo Pharma Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 24.42% of the total equity shares of Aurobindo Pharma Ltd.

How has the Aurobindo Pharma Ltd promoter holding changed?

The promoter holding in Aurobindo Pharma Ltd changed from 51.88% to 51.88% during the latest reported period.

How has the Aurobindo Pharma Ltd FII holding changed?

The FII holding in Aurobindo Pharma Ltd changed from 16.38% to 17.41% during the latest reported period.

How has the Aurobindo Pharma Ltd DII holding changed?

The DII holding in Aurobindo Pharma Ltd changed from 25.10% to 24.42% during the latest reported period.

Who are the major shareholders of Aurobindo Pharma Ltd?

The major shareholders of Aurobindo Pharma Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Aurobindo Pharma Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Aurobindo Pharma Ltd public shareholding?

Public shareholders hold 6.29% of the total equity shares of Aurobindo Pharma Ltd as per the latest available data.

Aurobindo Pharma Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln LrgNSE

₹1,571.70

-39.20(-2.43%)

As on 23 Oct 2026 at 15:59

As of 23 Oct 2026 at 15:59, Aurobindo Pharma Ltd is trading at ₹1,571.70. The 52-week range stands at ₹1,080.10–₹1,740.00, with a market cap of ₹90.29 thousand crore. At a P/E of 34.65 and a dividend yield of 0.26%, it is a large-cap stock in the Pharmaceuticals sector.